Literature DB >> 33400247

SP1-induced AFAP1-AS1 contributes to proliferation and invasion by regulating miR-497-5p/CELF1 pathway in nasopharyngeal carcinoma.

Hui Jin1, Gengtian Liang1, Liping Yang1, Li Liu1, Binru Wang1, Fengqin Yan2,3.   

Abstract

Nasopharyngeal carcinoma is a type of otolaryngological malignancy with high incidence. Long non-coding RNAs (lncRNAs) are closely related to nasopharyngeal carcinoma. LncRNA AFAP1-AS1 (AFAP1-AS1) has been found to play important roles in nasopharyngeal carcinoma progression and poor prognosis. However, the mechanism underlying AFAP1-AS1 in regulating nasopharyngeal carcinoma is still unclear. In current study, AFAP1-AS1 was found to be up-regulated in nasopharyngeal carcinoma tissues and cells. AFAP1-AS1 overexpression and knockdown were conducted in nasopharyngeal carcinoma cells. The results proved that AFAP1-AS1 promoted the survival and migration of nasopharyngeal carcinoma cells. Additionally, specificity protein 1 (SP1) was enhanced in nasopharyngeal carcinoma tissues and cells, and induced AFAP1-AS1 expression. The interaction between AFAP1-AS1 and miR-497-5p was confirmed. AFAP1-AS1 was demonstrated to regulate CELF1, a target gene of miR-497-5p. Further functional analysis revealed that AFAP1-AS1 knockdown attenuated SP1-induced nasopharyngeal carcinoma progression. These results indicate that SP1-induced AFAP1-AS1 facilitates nasopharyngeal carcinoma progression by regulating miR-497-5p/CELF1 pathway, which provides a new target for nasopharyngeal carcinoma treatment.

Entities:  

Keywords:  AFAP1-AS1; Nasopharyngeal carcinoma; SP1; miR-497-5p

Mesh:

Substances:

Year:  2021        PMID: 33400247     DOI: 10.1007/s13577-020-00475-y

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  32 in total

Review 1.  Nasopharyngeal carcinoma: the next challenges.

Authors:  Albiruni R A Razak; Lillian L Siu; Fei-Fei Liu; Emma Ito; Brian O'Sullivan; Kelvin Chan
Journal:  Eur J Cancer       Date:  2010-05-05       Impact factor: 9.162

Review 2.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

Review 3.  Long intronic noncoding RNA transcription: expression noise or expression choice?

Authors:  Rodrigo Louro; Anna S Smirnova; Sergio Verjovski-Almeida
Journal:  Genomics       Date:  2008-12-18       Impact factor: 5.736

4.  High expression of KPNA2 promotes colorectal cancer development by activating the PI3K/AKT pathway.

Authors:  B Huang; H Luo; X B Guo
Journal:  J Biol Regul Homeost Agents       Date:  2020 Nov-Dec       Impact factor: 1.711

Review 5.  Long noncoding RNAs during normal and malignant hematopoiesis.

Authors:  Juan R Alvarez-Dominguez; Wenqian Hu; Austin A Gromatzky; Harvey F Lodish
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

6.  Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.

Authors:  Lijun Wang; Yesong Guo; Jianhua Xu; Zhenzhang Chen; Xuesong Jiang; Lanfang Zhang; Shengfu Huang; Xia He; Yiqin Zhang
Journal:  Ann Otol Rhinol Laryngol       Date:  2017-10-12       Impact factor: 1.547

7.  miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.

Authors:  Nan Cheng; Guang-Hui Wang
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

8.  The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Tian Tian; Meng Wang; Shuai Lin; Yan Guo; Zhiming Dai; Kang Liu; Pengtao Yang; Cong Dai; Yuyao Zhu; Yi Zheng; Peng Xu; Wenge Zhu; Zhijun Dai
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-03       Impact factor: 8.886

9.  Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis.

Authors:  Yan He; Tao Guo; Hui Guan; Jingjing Wang; Yu Sun; Xingchen Peng
Journal:  Cancer Manag Res       Date:  2018-06-06       Impact factor: 3.989

Review 10.  Long noncoding RNAs: a potential novel class of cancer biomarkers.

Authors:  Aliaksandr A Yarmishyn; Igor V Kurochkin
Journal:  Front Genet       Date:  2015-04-23       Impact factor: 4.599

View more
  2 in total

1.  Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression.

Authors:  Ming-Jer Young; Yung-Ching Chen; Shao-An Wang; Hui-Ping Chang; Wen-Bin Yang; Chia-Chi Lee; Chia-Yu Liu; Yau-Lin Tseng; Yi-Ching Wang; H Sunny Sun; Wen-Chang Chang; Jan-Jong Hung
Journal:  J Biomed Sci       Date:  2022-01-17       Impact factor: 8.410

Review 2.  CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis.

Authors:  Maryam Nasiri-Aghdam; Texali C Garcia-Garduño; Luis Felipe Jave-Suárez
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.